VHT logo

Vanguard Health Care ETF (VHT)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Vanguard Health Care ETF (VHT) with AI Score 46/100 (Weak). Vanguard Health Care ETF (VHT) is a passively managed fund that seeks to track the investment return of stocks in the health care sector. Market cap: 0, Sector: Financial services.

Last analyzed: Mar 16, 2026
Vanguard Health Care ETF (VHT) is a passively managed fund that seeks to track the investment return of stocks in the health care sector. It employs a full-replication or sampling strategy to mirror the performance of its benchmark index.
46/100 AI Score

Vanguard Health Care ETF (VHT) Financial Services Profile

HeadquartersValley Forge, US
IPO Year2004

Vanguard Health Care ETF (VHT) offers investors exposure to a diversified portfolio of healthcare companies, tracking a benchmark index with a passive management approach. With a focus on medical products, services, technology, and equipment, VHT provides a cost-effective way to participate in the healthcare sector's growth, appealing to investors seeking sector-specific diversification.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

Vanguard Health Care ETF (VHT) presents a notable research candidate for those seeking exposure to the healthcare sector. With a market capitalization of $20.26 billion and a beta of 0.73, VHT offers relatively stable exposure to the healthcare market. The fund's passive management strategy, combined with its full-replication or sampling approach, aims to closely track the performance of its benchmark index, providing investors with a diversified portfolio of healthcare stocks. As the healthcare sector continues to grow due to factors like aging populations and technological advancements, VHT is positioned to benefit from this trend. However, investors should be aware that VHT does not offer a dividend yield.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $20.26B indicates substantial size and liquidity.
  • Beta of 0.73 suggests lower volatility compared to the broader market.
  • Passive management strategy aims to replicate the performance of a benchmark index.
  • Full-replication or sampling strategy ensures close tracking of the index.
  • Exposure to a diversified portfolio of healthcare stocks provides sector-specific investment.

Competitors & Peers

Strengths

  • Diversified exposure to the healthcare sector.
  • Low expense ratio.
  • Passively managed, tracking a benchmark index.
  • Strong brand recognition of Vanguard.

Weaknesses

  • No dividend yield.
  • Subject to market fluctuations in the healthcare sector.
  • Performance tied to the performance of the underlying index.
  • May not outperform actively managed healthcare funds.

Catalysts

  • Ongoing: Aging global population driving increased demand for healthcare services.
  • Ongoing: Technological advancements in medical devices and pharmaceuticals.
  • Ongoing: Expansion of healthcare access in emerging markets.
  • Upcoming: Potential for new drug approvals and medical breakthroughs.
  • Ongoing: Government healthcare policies and reforms.

Risks

  • Potential: Regulatory changes impacting the healthcare industry.
  • Potential: Economic downturns reducing healthcare spending.
  • Ongoing: Competition from other healthcare ETFs and investment options.
  • Potential: Patent expirations and generic drug competition.
  • Potential: Unforeseen events such as pandemics or major healthcare crises.

Growth Opportunities

  • Aging Population: The global aging population is a significant growth driver for the healthcare sector. As the number of older adults increases, so does the demand for healthcare services, medical devices, and pharmaceuticals. VHT is well-positioned to benefit from this demographic trend, as it provides exposure to companies involved in providing medical and health care products, services, technology, or equipment. This ongoing trend will continue to drive growth in the healthcare sector for the foreseeable future.
  • Technological Advancements: Continuous advancements in medical technology, such as gene therapy, robotic surgery, and artificial intelligence, are transforming the healthcare landscape. These innovations are creating new opportunities for companies involved in developing and commercializing cutting-edge medical solutions. VHT's portfolio includes companies at the forefront of these technological advancements, positioning it to capitalize on the growth potential of the medical technology sector. The impact of these advancements is expected to be seen in the next 5-10 years.
  • Emerging Markets: The rising middle class and increasing access to healthcare in emerging markets are driving demand for healthcare products and services. As these economies develop, their healthcare spending is expected to increase significantly. VHT's portfolio includes companies with a global presence, allowing it to benefit from the growth in emerging markets. This expansion into new markets is expected to unfold over the next decade.
  • Increased Healthcare Spending: Healthcare spending continues to rise in developed countries due to factors such as rising costs of medical treatments, increasing prevalence of chronic diseases, and expanding health insurance coverage. This trend is creating opportunities for companies involved in providing healthcare services, pharmaceuticals, and medical devices. VHT's exposure to these companies positions it to benefit from the overall increase in healthcare spending. This trend is expected to continue in the coming years.
  • Innovation in Pharmaceuticals: The pharmaceutical industry is constantly innovating, developing new drugs and therapies to treat a wide range of diseases. These innovations are creating opportunities for pharmaceutical companies to generate revenue and grow their businesses. VHT's portfolio includes pharmaceutical companies that are actively engaged in research and development, positioning it to benefit from the success of new drugs and therapies. The timeline for these innovations to impact the market varies depending on the drug development and approval process.

Opportunities

  • Growth in the healthcare sector due to aging population and technological advancements.
  • Increasing demand for healthcare services in emerging markets.
  • Potential for new drug approvals and medical breakthroughs.
  • Expansion of health insurance coverage.

Threats

  • Regulatory changes in the healthcare industry.
  • Economic downturns impacting healthcare spending.
  • Competition from other healthcare ETFs and mutual funds.
  • Patent expirations and generic drug competition.

Competitive Advantages

  • Brand Recognition: Vanguard is a well-known and respected brand in the investment management industry.
  • Low Expense Ratio: VHT offers a competitive expense ratio compared to other healthcare ETFs.
  • Diversification: VHT provides exposure to a broad range of healthcare companies, reducing risk.

About VHT

Vanguard Health Care ETF (VHT) is designed to provide investors with a convenient way to gain exposure to the broad healthcare sector through a single investment vehicle. The ETF operates under a passively managed strategy, aiming to replicate the performance of a specified benchmark index that represents the healthcare industry. This index comprises stocks of companies involved in various facets of healthcare, including medical or health care products, services, technology, and equipment. Vanguard employs a full-replication strategy whenever feasible, meaning it invests in all the stocks included in the benchmark index, mirroring its composition. However, when regulatory constraints or practical limitations arise, a sampling strategy is utilized, where the ETF invests in a representative sample of stocks that closely resemble the overall characteristics of the index. VHT's investment approach is geared towards providing investors with a cost-effective and diversified exposure to the healthcare sector, allowing them to participate in the potential growth and innovation within the industry.

What They Do

  • Tracks the performance of a benchmark index that measures the investment return of stocks in the health care sector.
  • Provides investors with exposure to a diversified portfolio of healthcare companies.
  • Employs a passively managed investment strategy.
  • Utilizes a full-replication strategy when possible to mirror the index.
  • Uses a sampling strategy when full replication is not feasible.
  • Includes stocks of companies involved in providing medical or health care products.
  • Includes stocks of companies involved in providing health care services.
  • Includes stocks of companies involved in providing health care technology or equipment.

Business Model

  • VHT generates revenue through management fees charged to investors.
  • The fund's expense ratio covers the costs of managing the portfolio and operating the ETF.
  • VHT's business model is based on providing investors with a cost-effective and diversified way to access the healthcare sector.

Industry Context

Vanguard Health Care ETF (VHT) operates within the asset management industry, specifically focusing on providing investors with exposure to the healthcare sector. The healthcare industry is characterized by consistent growth driven by factors such as an aging global population, increasing prevalence of chronic diseases, and advancements in medical technology. The ETF competes with other healthcare-focused ETFs and mutual funds, such as DFUS, FNDF, FTEC, IWS, and IWV, offering investors various options for accessing the healthcare market. The competitive landscape is shaped by factors such as expense ratios, tracking accuracy, and fund size.

Key Customers

  • Individual investors seeking exposure to the healthcare sector.
  • Institutional investors looking for a cost-effective way to diversify their portfolios.
  • Financial advisors recommending healthcare investments to their clients.
AI Confidence: 83% Updated: Mar 16, 2026

Financials

Chart & Info

Vanguard Health Care ETF (VHT) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VHT.

Price Targets

Wall Street price target analysis for VHT.

MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates VHT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

VHT Financial Services Stock FAQ

What does Vanguard Health Care ETF do?

Vanguard Health Care ETF (VHT) is designed to mirror the performance of a benchmark index that represents the healthcare sector. It achieves this by investing in a diversified portfolio of companies involved in providing medical or health care products, services, technology, or equipment. The ETF employs a passive management strategy, aiming to replicate the index's composition and performance as closely as possible. By offering exposure to a wide range of healthcare companies, VHT provides investors with a convenient and cost-effective way to participate in the growth and innovation within the healthcare industry.

What do analysts say about VHT stock?

AI analysis is pending for VHT. Generally, analysts evaluate healthcare ETFs like VHT based on factors such as expense ratio, tracking error, diversification, and exposure to specific sub-sectors within healthcare. Key valuation metrics include the fund's net asset value (NAV) and its performance relative to its benchmark index. Growth considerations revolve around the overall growth prospects of the healthcare sector, driven by factors such as aging populations, technological advancements, and increasing healthcare spending. Analyst consensus is pending.

What are the main risks for VHT?

Vanguard Health Care ETF (VHT) faces several risks inherent to the healthcare sector. Regulatory changes, such as healthcare reforms or drug pricing regulations, can significantly impact the profitability of companies within the ETF's portfolio. Economic downturns can lead to reduced healthcare spending, affecting the demand for healthcare services and products. Competition from other healthcare ETFs and investment options can also impact VHT's market share. Additionally, patent expirations and generic drug competition can erode the revenue of pharmaceutical companies within the fund.

How sensitive is VHT to changes in healthcare policy and regulation?

Vanguard Health Care ETF (VHT) is significantly sensitive to changes in healthcare policy and regulation. Government regulations and policies can directly impact the profitability and operations of healthcare companies within the ETF's portfolio. For example, changes in drug pricing regulations, healthcare reimbursement rates, or the Affordable Care Act can have a material impact on the financial performance of pharmaceutical companies, healthcare providers, and medical device manufacturers. These policy shifts can create uncertainty and volatility within the healthcare sector, affecting VHT's overall performance.

What is the impact of technological innovation on VHT's holdings?

Technological innovation has a significant impact on the holdings within Vanguard Health Care ETF (VHT). Advancements in medical technology, such as gene therapy, robotic surgery, and artificial intelligence, can create new opportunities for companies involved in developing and commercializing these innovations. Companies that are at the forefront of technological advancements may experience increased revenue and growth, positively impacting VHT's performance. However, disruptive technologies can also pose a threat to established companies, potentially leading to decreased revenue and market share. VHT's ability to adapt to and capitalize on technological innovation is crucial for its long-term success.

What are the key factors to evaluate for VHT?

Vanguard Health Care ETF (VHT) currently holds an AI score of 46/100, indicating low score. Key strength: Diversified exposure to the healthcare sector.. Primary risk to monitor: Potential: Regulatory changes impacting the healthcare industry.. This is not financial advice.

How frequently does VHT data refresh on this page?

VHT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven VHT's recent stock price performance?

Recent price movement in Vanguard Health Care ETF (VHT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified exposure to the healthcare sector.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for VHT. The information provided is based on available data and general knowledge of the company and industry. Investment decisions should be based on thorough research and consultation with a financial advisor.
Data Sources

Popular Stocks